Trending News
News
News
Helicos Launches Open Access Web Site with Microbial Genome Data
The Company launches, HeliSphere™ Technology Center, an open access Web site for sharing Helicos data sets and bioinformatics software tools.
News
AnaSpec Establishes new Dedicated GMP Manufacturing Facility
The expansion provides an additional 5000 sq. ft. of GMP space including two class 10,000 clean rooms.
News
Pfizer Launches Global Regenerative Medicine Research Unit
The new independent research unit will provide new generation of regenerative medicines for major medical needs.
News
Pfizer and UCB Announce Formation of New Company 'Cyclofluidic' to Accelerate Drug Discovery Process
The aim of Cyclofluidic is to develop technologies to help pharmaceutical companies shorten timelines within the drug development process.
News
New Acquisition Expands Sequencing Install Base to 37 Illumina Genome Analyzers
Sanger Institute has purchased 11 additional Genome Analyzers to scale up its initiative to contribute to the 1000 Genome Project.
News
Delphi Genetics and Eurogentec Biologics Collaborate for Antibiotic Resistance-Gene Free GMP Manufacturing
Under the agreement Eurogentec will promote Delphi Genetics’ StabyDNA technology for use in GMP manufacturing on an exclusive basis.
News
BioSeek Licenses Two Novel Anti-Inflammatory Peptides
The two peptides, licensed from Amylin Pharmaceuticals, were identified as candidates for development in ongoing research collaboration between the two companies.
News
BioFocus DPI and ZoBio Announce Marketing Agreement
Both companies have signed a worldwide marketing and sales agreement for ZoBio’s fragment-based NMR technologies.
News
Lorus Completes IND-Enabling Toxicology Studies for Lead Small Molecule Anticancer Drug LOR-253
The drug LOR-253 shows induction of KLF4, a tumor suppressor factor that is reduced in a variety of important cancers.
News
Affymetrix to Acquire Panomics
The assay products for low to mid-plex applications will strengthen company's position in high-growth validation and routine-testing markets.
Advertisement